SHENZHEN HEPALINK PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss
The total revenue of 9989 for the last quarter is 1.49 B HKD, and it's 0.42% higher compared to the previous quarter. The net income of Q1 24 is 168.68 M HKD.